• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
RNA Fibers as Optimized Nanoscaffolds for siRNA Coordination and Reduced Immunological Recognition.RNA纤维作为用于siRNA协同和降低免疫识别的优化纳米支架
Adv Funct Mater. 2018 Nov 28;28(48). doi: 10.1002/adfm.201805959. Epub 2018 Oct 9.
2
Combination of Nucleic Acid and Mesoporous Silica Nanoparticles: Optimization and Therapeutic Performance In Vitro.核酸与介孔硅纳米粒子的结合:体外优化及治疗性能。
ACS Appl Mater Interfaces. 2020 Sep 2;12(35):38873-38886. doi: 10.1021/acsami.0c07106. Epub 2020 Aug 18.
3
Functionalized bioengineered spider silk spheres improve nuclease resistance and activity of oligonucleotide therapeutics providing a strategy for cancer treatment.功能化生物工程蜘蛛丝球体提高核酸酶抗性和寡核苷酸疗法的活性,为癌症治疗提供了一种策略。
Acta Biomater. 2017 Sep 1;59:221-233. doi: 10.1016/j.actbio.2017.07.014. Epub 2017 Jul 8.
4
RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.通过聚乙烯亚胺复合小干扰RNA在体内对多效生长因子进行RNA干扰介导的基因沉默,可对胶质母细胞瘤异种移植瘤发挥抗肿瘤作用。
Hum Gene Ther. 2006 Jul;17(7):751-66. doi: 10.1089/hum.2006.17.751.
5
Exosome mediated delivery of functional nucleic acid nanoparticles (NANPs).外泌体介导的功能性核酸纳米颗粒(NANPs)的递释。
Nanomedicine. 2020 Nov;30:102285. doi: 10.1016/j.nano.2020.102285. Epub 2020 Aug 8.
6
A cationic amphiphilic co-polymer as a carrier of nucleic acid nanoparticles (Nanps) for controlled gene silencing, immunostimulation, and biodistribution.阳离子两亲共聚物作为核酸纳米颗粒(Nanps)的载体,用于控制基因沉默、免疫刺激和生物分布。
Nanomedicine. 2020 Jan;23:102094. doi: 10.1016/j.nano.2019.102094. Epub 2019 Oct 25.
7
Long dsRNA-mediated RNA interference and immunostimulation: a targeted delivery approach using polyethyleneimine based nano-carriers.长双链RNA介导的RNA干扰和免疫刺激:一种使用基于聚乙烯亚胺的纳米载体的靶向递送方法。
Mol Pharm. 2014 Mar 3;11(3):872-84. doi: 10.1021/mp400541z. Epub 2014 Feb 20.
8
Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: a promising approach in liver-specific RNAi delivery.基于三足 RNA 的纳米粒子引发的高效细胞内递送和多靶点基因沉默:肝特异性 RNAi 递送的有前途方法。
J Control Release. 2014 Dec 28;196:28-36. doi: 10.1016/j.jconrel.2014.09.016. Epub 2014 Sep 20.
9
Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine.用于自动化纳米医学的 siRNA 功能化 RNA 纳米颗粒的设计和自组装。
Nat Protoc. 2011 Dec 1;6(12):2022-34. doi: 10.1038/nprot.2011.418.
10
A novel tyrosine-modified low molecular weight polyethylenimine (P10Y) for efficient siRNA delivery in vitro and in vivo.一种新型的酪氨酸修饰的低分子量聚乙二烯亚胺(P10Y),可在体外和体内有效递送 siRNA。
J Control Release. 2016 May 28;230:13-25. doi: 10.1016/j.jconrel.2016.03.034. Epub 2016 Apr 7.

引用本文的文献

1
Leveraging Immunological Properties of Nucleic Acid Nanoparticles to Improve Cancer Therapy.利用核酸纳米颗粒的免疫学特性改善癌症治疗
RNA Nanomed. 2025 Apr;2(1). doi: 10.59566/isrnn.2025.0201b.
2
The Reduction of Traumatic Spinal Cord Secondary Injury by Anti-RhoA siRNA Functionalized Nucleic Acid Nanoparticles (NANPs).抗RhoA小干扰RNA功能化核酸纳米颗粒(NANPs)减轻创伤性脊髓继发性损伤
RNA Nanomed. 2024;1(1):79-90. doi: 10.59566/isrnn.2024.0101079.
3
Design and Characterization of DNA-Driven Condensates: Regulating Topology, Mechanical Properties, and Immunorecognition.DNA驱动凝聚物的设计与表征:调控拓扑结构、力学性能和免疫识别
ACS Appl Mater Interfaces. 2025 Apr 16;17(15):22322-22336. doi: 10.1021/acsami.5c00428. Epub 2025 Apr 1.
4
Epigenetic Mechanisms in Osteoporosis: Exploring the Power of mA RNA Modification.骨质疏松症中的表观遗传机制:探索m⁶A RNA修饰的作用
J Cell Mol Med. 2025 Jan;29(1):e70344. doi: 10.1111/jcmm.70344.
5
Autonomous Nucleic Acid and Protein Nanocomputing Agents Engineered to Operate in Living Cells.经设计可在活细胞中运行的自主核酸和蛋白质纳米计算剂。
ACS Nano. 2025 Jan 21;19(2):1865-1883. doi: 10.1021/acsnano.4c13663. Epub 2025 Jan 6.
6
Development of an RNA Nanostructure for Effective Control through Spray-Induced Gene Silencing without an Extra Nanocarrier.通过喷雾诱导基因沉默实现有效控制且无需额外纳米载体的RNA纳米结构的开发。
J Fungi (Basel). 2024 Jul 14;10(7):483. doi: 10.3390/jof10070483.
7
Assessment of Intracellular Compartmentalization of RNA Nanostructures.评估 RNA 纳米结构的细胞内区室化。
Methods Mol Biol. 2023;2709:211-228. doi: 10.1007/978-1-0716-3417-2_14.
8
Synthesis of Mesoporous Silica Nanoparticles for the Delivery of Nucleic Acid Nanostructures.用于递送核酸纳米结构的介孔二氧化硅纳米颗粒的合成
Methods Mol Biol. 2023;2709:205-210. doi: 10.1007/978-1-0716-3417-2_13.
9
Light-Assisted Drying for the Thermal Stabilization of Nucleic Acid Nanoparticles and Other Biologics.光照辅助干燥用于核酸纳米颗粒和其他生物制剂的热稳定化。
Methods Mol Biol. 2023;2709:117-130. doi: 10.1007/978-1-0716-3417-2_7.
10
Structural Characterization of Nucleic Acid Nanoparticles Using SAXS and SAXS-Driven MD.使用小角 X 射线散射(SAXS)和 SAXS 驱动的 MD 对核酸纳米粒子进行结构表征。
Methods Mol Biol. 2023;2709:65-94. doi: 10.1007/978-1-0716-3417-2_4.

本文引用的文献

1
Structure and Composition Define Immunorecognition of Nucleic Acid Nanoparticles.结构和组成决定核酸纳米颗粒的免疫识别。
Nano Lett. 2018 Jul 11;18(7):4309-4321. doi: 10.1021/acs.nanolett.8b01283. Epub 2018 Jun 20.
2
Composing RNA Nanostructures from a Syntax of RNA Structural Modules.从 RNA 结构模块的语法构建 RNA 纳米结构。
Nano Lett. 2017 Nov 8;17(11):7095-7101. doi: 10.1021/acs.nanolett.7b03842. Epub 2017 Oct 25.
3
Programmable Nucleic Acid Based Polygons with Controlled Neuroimmunomodulatory Properties for Predictive QSAR Modeling.可编程核酸基多形体,具有可控的神经免疫调节特性,用于预测性 QSAR 建模。
Small. 2017 Nov;13(42). doi: 10.1002/smll.201701255. Epub 2017 Sep 18.
4
Protein-driven RNA nanostructured devices that function in vitro and control mammalian cell fate.在体外发挥作用并控制哺乳动物细胞命运的蛋白质驱动的RNA纳米结构装置。
Nat Commun. 2017 Sep 14;8(1):540. doi: 10.1038/s41467-017-00459-x.
5
Role of Type I and II Interferons in Colorectal Cancer and Melanoma.I型和II型干扰素在结直肠癌和黑色素瘤中的作用。
Front Immunol. 2017 Jul 26;8:878. doi: 10.3389/fimmu.2017.00878. eCollection 2017.
6
Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer.刺激响应性介孔二氧化硅纳米粒子作为三阴性乳腺癌的非病毒双siRNA/化疗载体
Mol Ther Nucleic Acids. 2017 Jun 16;7:164-180. doi: 10.1016/j.omtn.2017.03.007. Epub 2017 Mar 29.
7
Mucin-1-Antibody-Conjugated Mesoporous Silica Nanoparticles for Selective Breast Cancer Detection in a Mucin-1 Transgenic Murine Mouse Model.用于在粘蛋白-1转基因小鼠模型中选择性检测乳腺癌的粘蛋白-1抗体偶联介孔二氧化硅纳米颗粒
J Biomed Nanotechnol. 2016 Dec;12(12):2172-2184. doi: 10.1166/jbn.2016.2318.
8
Mesoporous Silica Nanoparticles as Carriers for Intracellular Delivery of Nucleic Acids and Subsequent Therapeutic Applications.介孔二氧化硅纳米颗粒作为核酸细胞内递送及后续治疗应用的载体
Molecules. 2017 May 11;22(5):782. doi: 10.3390/molecules22050782.
9
Functionally-interdependent shape-switching nanoparticles with controllable properties.具有可控性质的功能相互依赖的形状转换纳米颗粒。
Nucleic Acids Res. 2017 Feb 28;45(4):2210-2220. doi: 10.1093/nar/gkx008.
10
Versatile RNA tetra-U helix linking motif as a toolkit for nucleic acid nanotechnology.多功能RNA四聚体U螺旋连接基序作为核酸纳米技术的一种工具
Nanomedicine. 2017 Apr;13(3):1137-1146. doi: 10.1016/j.nano.2016.12.018. Epub 2017 Jan 4.

RNA纤维作为用于siRNA协同和降低免疫识别的优化纳米支架

RNA Fibers as Optimized Nanoscaffolds for siRNA Coordination and Reduced Immunological Recognition.

作者信息

Rackley Lauren, Stewart Jaimie Marie, Salotti Jacqueline, Krokhotin Andrey, Shah Ankit, Halman Justin R, Juneja Ridhima, Smollett Jaclyn, Lee Lauren, Roark Kyle, Viard Mathias, Tarannum Mubin, Vivero-Escoto Juan, Johnson Peter F, Dobrovolskaia Marina A, Dokholyan Nikolay V, Franco Elisa, Afonin Kirill A

机构信息

Nanoscale Science Program, Department of Chemistry, University of North Carolina at Charlotte, Charlotte, NC 28223, USA.

Department of Bioengineering, University of California, Riverside, CA 92521, USA.

出版信息

Adv Funct Mater. 2018 Nov 28;28(48). doi: 10.1002/adfm.201805959. Epub 2018 Oct 9.

DOI:10.1002/adfm.201805959
PMID:31258458
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6599627/
Abstract

RNA is a versatile biomaterial that can be used to engineer nanoassemblies for personalized treatment of various diseases. Despite promising advancements, the design of RNA nanoassemblies with minimal recognition by the immune system remains a major challenge. Here, an approach is reported to engineer RNA fibrous structures to operate as a customizable platform for efficient coordination of siRNAs and for maintaining low immunostimulation. Functional RNA fibers are studied in silico and their formation is confirmed by various experimental techniques and visualized by atomic force microscopy (AFM). It is demonstrated that the RNA fibers offer multiple advantages among which are: i) programmability and modular design that allow for simultaneous controlled delivery of multiple siRNAs and fluorophores, ii) reduced immunostimulation when compared to other programmable RNA nanoassemblies, and iii) simple production protocol for endotoxin-free fibers with the option of their cotranscriptional assembly. Furthermore, it is shown that functional RNA fibers can be efficiently delivered with various organic and inorganic carriers while retaining their structural integrity in cells. Specific gene silencing triggered by RNA fibers is assessed in human breast cancer and melanoma cell lines, with the confirmed ability of functional fibers to selectively target single nucleotide mutations.

摘要

RNA是一种多功能生物材料,可用于构建纳米组装体,以实现对各种疾病的个性化治疗。尽管取得了令人鼓舞的进展,但设计出能被免疫系统最少识别的RNA纳米组装体仍是一项重大挑战。在此,报道了一种构建RNA纤维结构的方法,该结构可作为一个可定制平台,用于高效协调小干扰RNA(siRNA)并保持低免疫刺激。对功能性RNA纤维进行了计算机模拟研究,并用各种实验技术证实了其形成过程,还通过原子力显微镜(AFM)进行了可视化观察。结果表明,RNA纤维具有多种优势,其中包括:i)可编程性和模块化设计,可同时控制多种siRNA和荧光团的递送;ii)与其他可编程RNA纳米组装体相比,免疫刺激降低;iii)生产无内毒素纤维的简单方案,可选择共转录组装。此外,研究表明,功能性RNA纤维可以通过各种有机和无机载体有效递送,同时在细胞中保持其结构完整性。在人乳腺癌和黑色素瘤细胞系中评估了RNA纤维引发的特异性基因沉默,证实了功能性纤维能够选择性靶向单核苷酸突变。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/891e92b69370/nihms-1027882-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/99b2c0ba1ee4/nihms-1027882-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/4d8054fcb3de/nihms-1027882-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/a86809c010e5/nihms-1027882-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/433ae7627929/nihms-1027882-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/e3114710950c/nihms-1027882-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/b8d01dfd4367/nihms-1027882-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/4a3b225d5bd3/nihms-1027882-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/891e92b69370/nihms-1027882-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/99b2c0ba1ee4/nihms-1027882-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/4d8054fcb3de/nihms-1027882-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/a86809c010e5/nihms-1027882-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/433ae7627929/nihms-1027882-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/e3114710950c/nihms-1027882-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/b8d01dfd4367/nihms-1027882-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/4a3b225d5bd3/nihms-1027882-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b48c/6599627/891e92b69370/nihms-1027882-f0008.jpg